Poland Pharmaceuticals & Healthcare Views

Pages

Lundbeck launches Selincro in Europe

Lundbeck has shipped Selincro (nalmefene) in its first markets and made the product available for alcohol dependent patients with high-risk drinking levels (>60g/day for men, >40g/day for women)...

Read article ›

Pages